Hu Xin, Zhu Bo, Vokes Natalie, Fujimoto Junya, Rojas Alvarez Frank R, Heeke Simon, Moreira Andre L, Solis Luisa M, Haymaker Cara, Velcheti Vamsidhar, Sterman Daniel H, Pass Harvey I, Cheng Chao, Lee Jack J, Zhang Jianhua, Wei Zhubo, Wu Jia, Le Xiuning, Ostrin Edwin, Toumazis Iakovos, Gibbons Don, Su Dan, Fukuoka Junya, Antonoff Mara B, Gerber David E, Li Chenyang, Kadara Humam, Wang Linghua, Davis Mark, Heymach John V, Hannash Samir, Wistuba Ignacio, Dubinett Steven, Alexandrov Ludmil, Lippman Scott, Spira Avrum, Futreal Andrew P, Reuben Alexandre, Zhang Jianjun
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Departments of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Res Sq. 2024 May 15:rs.3.rs-4396272. doi: 10.21203/rs.3.rs-4396272/v1.
Studying lung adenocarcinoma (LUAD) early carcinogenesis is challenging, primarily due to the lack of LUAD precursors specimens. We amassed multi-omics data from 213 LUAD and LUAD precursors to identify molecular features underlying LUAD precancer evolution. We observed progressively increasing mutations, chromosomal aberrations, whole genome doubling and genomic instability from precancer to invasive LUAD, indicating aggravating chromosomal instability (CIN). Telomere shortening, a crucial genomic alteration linked to CIN, emerged at precancer stage. Moreover, later-stage lesions demonstrated increasing cancer stemness and decreasing alveolar identity, suggesting epithelial de-differentiation during early LUAD carcinogenesis. The innate immune cells progressively diminished from precancer to invasive LUAD, concomitant with a gradual recruitment of adaptive immune cells (except CD8 and gamma-delta T cells that decreased in later stages) and upregulation of numerous immune checkpoints, suggesting LUAD precancer evolution is associated with a shift from innate to adaptive immune response and immune evasion mediated by various mechanisms.
研究肺腺癌(LUAD)的早期致癌过程具有挑战性,主要原因是缺乏LUAD前驱病变标本。我们收集了来自213例LUAD及其前驱病变的多组学数据,以确定LUAD癌前病变演变的分子特征。我们观察到,从癌前病变到浸润性LUAD,突变、染色体畸变、全基因组加倍和基因组不稳定性逐渐增加,表明染色体不稳定性(CIN)加剧。端粒缩短是一种与CIN相关的关键基因组改变,在癌前阶段就已出现。此外,后期病变显示癌症干性增加,肺泡特征减少,表明LUAD早期致癌过程中存在上皮细胞去分化。从癌前病变到浸润性LUAD,固有免疫细胞逐渐减少,同时适应性免疫细胞逐渐募集(CD8和γδT细胞后期减少除外),且多种免疫检查点上调,这表明LUAD癌前病变演变与从固有免疫反应向适应性免疫反应的转变以及由多种机制介导的免疫逃逸有关。